• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

随着时间推移,通过脑脊液/血浆白蛋白比率测量阿尔茨海默病患者血脑屏障渗漏的进展情况。

Progression of Blood-Brain Barrier Leakage in Patients with Alzheimer's Disease as Measured with the Cerebrospinal Fluid/Plasma Albumin Ratio Over Time.

作者信息

Musaeus Christian Sandøe, Gleerup Helena Sophia, Hasselbalch Steen Gregers, Waldemar Gunhild, Simonsen Anja Hviid

机构信息

Department of Neurology, Danish Dementia Research Centre, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.

Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

出版信息

J Alzheimers Dis Rep. 2023 Jun 2;7(1):535-541. doi: 10.3233/ADR-230016. eCollection 2023.

DOI:10.3233/ADR-230016
PMID:37313491
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10259070/
Abstract

BACKGROUND

Studies have found a disruption of the blood-brain barrier (BBB) in patients with Alzheimer's disease (AD), but there is little evidence of the changes in the BBB over time. The cerebrospinal fluid's (CSF) protein concentration can be used as an indirect measurement for the permeability of the BBB using the CSF/plasma albumin quotient (Q-Alb) or total CSF protein.

OBJECTIVE

In the current study, we wanted to investigate the changes in Q-Alb in patients with AD over time.

METHODS

A total of 16 patients diagnosed with AD, who had at least two lumbar punctures performed, were included in the current study.

RESULTS

The difference in Q-Alb over time did not show a significant change. However, Q-Alb increased over time if the time interval was > 1 year between the measurements. No significant associations between Q-Alb and age, Mini-Mental State Examination, or AD biomarkers were found.

CONCLUSION

The increase in Q-Alb suggests that there is an increased leakage through the BBB, which may become more prominent as the disease progresses. This may be a sign of progressive underlying vascular pathology, even in patients with AD without major vascular lesions. More studies are needed to further understand the role of BBB integrity in patients with AD over time and the association with the progression of the disease.

摘要

背景

研究发现阿尔茨海默病(AD)患者存在血脑屏障(BBB)破坏,但几乎没有证据表明血脑屏障随时间发生变化。脑脊液(CSF)蛋白浓度可通过脑脊液/血浆白蛋白商(Q-Alb)或脑脊液总蛋白作为血脑屏障通透性的间接测量指标。

目的

在本研究中,我们想调查AD患者Q-Alb随时间的变化。

方法

本研究纳入了16例诊断为AD且至少进行过两次腰椎穿刺的患者。

结果

Q-Alb随时间的差异未显示出显著变化。然而,如果两次测量之间的时间间隔>1年,Q-Alb会随时间增加。未发现Q-Alb与年龄、简易精神状态检查或AD生物标志物之间存在显著关联。

结论

Q-Alb升高表明血脑屏障的渗漏增加,随着疾病进展可能会更加明显。这可能是潜在血管病变进展的迹象,即使在没有主要血管病变的AD患者中也是如此。需要更多研究来进一步了解血脑屏障完整性在AD患者随时间变化中的作用以及与疾病进展的关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aef/10259070/edb9028d5aec/adr-7-adr230016-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aef/10259070/423043e8ab63/adr-7-adr230016-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aef/10259070/edb9028d5aec/adr-7-adr230016-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aef/10259070/423043e8ab63/adr-7-adr230016-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aef/10259070/edb9028d5aec/adr-7-adr230016-g002.jpg

相似文献

1
Progression of Blood-Brain Barrier Leakage in Patients with Alzheimer's Disease as Measured with the Cerebrospinal Fluid/Plasma Albumin Ratio Over Time.随着时间推移,通过脑脊液/血浆白蛋白比率测量阿尔茨海默病患者血脑屏障渗漏的进展情况。
J Alzheimers Dis Rep. 2023 Jun 2;7(1):535-541. doi: 10.3233/ADR-230016. eCollection 2023.
2
Cerebrospinal fluid/serum albumin quotient (Q-Alb) is not increased in Alzheimer's disease compared to neurological disease controls: a retrospective study on 276 patients.脑脊髓液/血清白蛋白比值(Q-Alb)在阿尔茨海默病中与神经疾病对照组相比没有增加:对 276 例患者的回顾性研究。
Neurol Sci. 2023 Feb;44(2):709-713. doi: 10.1007/s10072-022-06530-w. Epub 2022 Nov 28.
3
Cerebrospinal Fluid/Plasma Albumin Ratio as a Biomarker for Blood-Brain Barrier Impairment Across Neurodegenerative Dementias.脑脊液/血浆白蛋白比值作为神经退行性痴呆血脑屏障损伤的生物标志物。
J Alzheimers Dis. 2020;75(2):429-436. doi: 10.3233/JAD-200168.
4
Changes in CSF sPDGFRβ level and their association with blood-brain barrier breakdown in Alzheimer's disease with or without small cerebrovascular lesions.阿尔茨海默病伴或不伴小血管病变患者 CSF sPDGFRβ 水平的变化及其与血脑屏障破坏的关系。
Alzheimers Res Ther. 2023 Mar 14;15(1):51. doi: 10.1186/s13195-023-01199-5.
5
Use of albumin quotient and IgG index to differentiate blood- vs brain-derived proteins in the cerebrospinal fluid of cats with feline infectious peritonitis.利用白蛋白商数和免疫球蛋白指数鉴别猫传染性腹膜炎猫脑脊液中血液来源与脑来源的蛋白质。
Vet Clin Pathol. 2008 Jun;37(2):207-16. doi: 10.1111/j.1939-165X.2008.00028.x.
6
Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a Natural Population of Cognitive Intact Parkinson's Disease Patients.认知功能正常的帕金森病患者自然人群中的脑脊液阿尔茨海默病生物标志物与血脑屏障完整性。
CNS Neurol Disord Drug Targets. 2017;16(3):339-345. doi: 10.2174/1871527316666161205123123.
7
Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio.通过脑脊液-血清白蛋白比率研究老年痴呆患者的血脑屏障通透性。
Intern Med. 1998 Jun;37(6):509-13. doi: 10.2169/internalmedicine.37.509.
8
Relationship between cerebrospinal fluid/serum albumin quotient and phenotype in amyotrophic lateral sclerosis: a retrospective study on 328 patients.脑脊髓液/血清白蛋白比值与肌萎缩侧索硬化症表型的关系:328 例患者的回顾性研究。
Neurol Sci. 2023 May;44(5):1679-1685. doi: 10.1007/s10072-023-06604-3. Epub 2023 Jan 17.
9
CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients.痴呆患者脑脊液/血清白蛋白比值:对1861例患者的横断面研究
Neurobiol Aging. 2017 Nov;59:1-9. doi: 10.1016/j.neurobiolaging.2017.06.028. Epub 2017 Jul 11.
10
Correlation of blood-brain barrier leakage with cerebral small vessel disease including cerebral microbleeds in Alzheimer's disease.血脑屏障渗漏与包括阿尔茨海默病脑微出血在内的脑小血管疾病的相关性。
Front Neurol. 2023 Feb 16;14:1077860. doi: 10.3389/fneur.2023.1077860. eCollection 2023.

引用本文的文献

1
Compartment-specific analysis reveals disrupted astrocytic calcium transients in Alzheimer's mice.特定脑区分析揭示阿尔茨海默病小鼠星形胶质细胞钙瞬变异常。
Res Sq. 2025 Jun 15:rs.3.rs-6682029. doi: 10.21203/rs.3.rs-6682029/v1.
2
Decreased water exchange rate across the blood-brain barrier throughout the Alzheimer's disease continuum: Evidence from Chinese data.阿尔茨海默病连续病程中血脑屏障水交换率降低:来自中国数据的证据。
Alzheimers Dement. 2025 Mar;21(3):e70089. doi: 10.1002/alz.70089.
3
Evaluation of Blood-Brain Barrier Disruption Using Low- and High-Molecular-Weight Complexes in a Single Brain Sample in a Rat Traumatic Brain Injury Model: Comparison to an Established Magnetic Resonance Imaging Technique.

本文引用的文献

1
Changes in CSF sPDGFRβ level and their association with blood-brain barrier breakdown in Alzheimer's disease with or without small cerebrovascular lesions.阿尔茨海默病伴或不伴小血管病变患者 CSF sPDGFRβ 水平的变化及其与血脑屏障破坏的关系。
Alzheimers Res Ther. 2023 Mar 14;15(1):51. doi: 10.1186/s13195-023-01199-5.
2
Upwards Drift of Cerebrospinal Fluid Amyloid-β 42 Over Twelve Years in a Consecutive Clinical Cohort.连续临床队列中十二年内脑脊液淀粉样蛋白-β 42 的向上漂移。
J Alzheimers Dis. 2021;81(4):1369-1373. doi: 10.3233/JAD-201506.
3
APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline.
在大鼠创伤性脑损伤模型中,使用单一脑样本中的低和高分子量复合物评估血脑屏障破坏:与一种已建立的磁共振成像技术的比较。
Int J Mol Sci. 2024 Oct 19;25(20):11241. doi: 10.3390/ijms252011241.
4
Linking peripheral atherosclerosis to blood-brain barrier disruption: elucidating its role as a manifestation of cerebral small vessel disease in vascular cognitive impairment.将周围动脉粥样硬化与血脑屏障破坏联系起来:阐明其作为血管性认知障碍中小血管疾病表现的作用。
Geroscience. 2024 Dec;46(6):6511-6536. doi: 10.1007/s11357-024-01194-0. Epub 2024 Jun 3.
5
Cognitive decline, Aβ pathology, and blood-brain barrier function in aged 5xFAD mice.老年 5xFAD 小鼠的认知能力下降、Aβ 病理学和血脑屏障功能。
Fluids Barriers CNS. 2024 Mar 27;21(1):29. doi: 10.1186/s12987-024-00531-x.
载脂蛋白 E4 导致血脑屏障功能障碍,预测认知能力下降。
Nature. 2020 May;581(7806):71-76. doi: 10.1038/s41586-020-2247-3. Epub 2020 Apr 29.
4
A novel sensitive assay for detection of a biomarker of pericyte injury in cerebrospinal fluid.一种用于检测脑脊液中周细胞损伤生物标志物的新型敏感检测方法。
Alzheimers Dement. 2020 Jun;16(6):821-830. doi: 10.1002/alz.12061. Epub 2020 Apr 16.
5
Cerebrospinal Fluid/Plasma Albumin Ratio as a Biomarker for Blood-Brain Barrier Impairment Across Neurodegenerative Dementias.脑脊液/血浆白蛋白比值作为神经退行性痴呆血脑屏障损伤的生物标志物。
J Alzheimers Dis. 2020;75(2):429-436. doi: 10.3233/JAD-200168.
6
Evidence for sex difference in the CSF/plasma albumin ratio in ~20 000 patients and 335 healthy volunteers.约 20000 名患者和 335 名健康志愿者的脑脊液/血浆白蛋白比值存在性别差异的证据。
J Cell Mol Med. 2018 Oct;22(10):5151-5154. doi: 10.1111/jcmm.13767. Epub 2018 Jul 27.
7
Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.阿尔茨海默病和其他神经退行性疾病中的血脑屏障破坏。
Nat Rev Neurol. 2018 Mar;14(3):133-150. doi: 10.1038/nrneurol.2017.188. Epub 2018 Jan 29.
8
CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients.痴呆患者脑脊液/血清白蛋白比值:对1861例患者的横断面研究
Neurobiol Aging. 2017 Nov;59:1-9. doi: 10.1016/j.neurobiolaging.2017.06.028. Epub 2017 Jul 11.
9
Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype.血脑屏障通透性增加与痴呆症和糖尿病有关,但与淀粉样蛋白病理或载脂蛋白E基因型无关。
Neurobiol Aging. 2017 Mar;51:104-112. doi: 10.1016/j.neurobiolaging.2016.11.017. Epub 2016 Dec 5.
10
Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease.早期阿尔茨海默病患者的血脑屏障渗漏。
Radiology. 2016 Nov;281(2):527-535. doi: 10.1148/radiol.2016152244. Epub 2016 May 31.